Read time: 4 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts
Read time: 9 minutes. More than 22,000 cancer researchers from 81 countries got together for the annual American Association for Cancer Research (AACR) meeting in Chicago from
Read time: 8 minutes. Narjust Florez, MD, is the associate director of the Cancer Care Equity Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center
Read time: 2 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts
Read time: 2 minutes. Historically, approaches to treating lung cancer included surgery, radiation, and chemotherapy. The past decade ushered in a new era of treatments with
Read time: 4 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts
Read time: 4 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts
Read time: 2 minutes. Researchers have been trying to find new ways to treat small cell lung cancer (SCLC) for a long time. Those efforts are starting to pay off in big ways. Join
Read time: 2 minutes. Here we present the final video in our three-part series about how patients and researchers can work together to develop clinical trials. In the video below
Read time: 2 minutes. We are pleased to continue our three-part series about how patients and researchers can work together to develop clinical trials. In this second video
Read time: 3 minutes. Throughout 2024 we published blogs sharing scientific meeting recaps, educational content, personal stories, treatment news, and so much more. Below are the
LUNGevity had a tremendous year supporting impactful research in 2024. In addition to our existing portfolio of ongoing research grants, we issued several new research awards in